-R A Nash Researcher Activity Profile

Research Author Detailed Information 

R A Nash Publication Rate By Year

R A Nash has published 1 paper(s) in 2006, 7 paper(s) in 2007, 3 paper(s) in 2008, for a total of 11 research publications in total.

R A Ra Nash Author Information

LAST NAME: nash

FIRST NAME: R A

INITIALS: ra

AFFILIATION:

Papers

R A Nash's Publication Record

1. Optimized transduction of canine paediatric CD34(+) cells using an MSCV-based bicistronic vector. Year Published: 2006
Section of Medical Genetics, Department of Clinical Studies, Philadelphia, Pennsylvania, USA. sesuter@vmth.ucdavis.edu
2. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Year Published: 2007
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. rnash@fhcrc.org
3. Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection. Year Published: 2007
Transplantation Biology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
4. Stability of benzoyl peroxide in aromatic ester-containing topical formulations. Year Published: 2007
Ortho-McNeil Pharmaceutical, a Johnson & Johnson Company, Raritan, NJ, USA.
5. Stability of benzoyl peroxide in aromatic ester-containing topical formulations. Year Published: 2007
Ortho-McNeil Pharmaceutical, a Johnson & Johnson Company, Raritan, NJ 08869, USA. bmajekod@psgus.jnj.com
6. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? Year Published: 2008
Department of Pathology, University of Washington, Seattle, Washington, United States of America.
7. Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection. Year Published: 2007
Transplantation Biology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
8. Stability of benzoyl peroxide in aromatic ester-containing topical formulations. Year Published: 2007
Ortho-McNeil Pharmaceutical, a Johnson & Johnson Company, Raritan, NJ 08869, USA. bmajekod@psgus.jnj.com
9. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? Year Published: 2008
Department of Pathology, University of Washington, Seattle, Washington, United States of America.
10. Autologous HSCT for advanced MS: is the glass half-empty or really half-full? Year Published: 2008
11. Stability of benzoyl peroxide in aromatic ester-containing topical formulations. Year Published: 2007
Ortho-McNeil Pharmaceutical, a Johnson & Johnson Company, Raritan, NJ 08869, USA. bmajekod@psgus.jnj.com